Bone Biologics Management
Management criteria checks 4/4
Bone Biologics' CEO is Jeff Frelick, appointed in Jun 2019, has a tenure of 4.92 years. total yearly compensation is $376.60K, comprised of 79.7% salary and 20.3% bonuses, including company stock and options. directly owns 0.24% of the company’s shares, worth $4.09K. The average tenure of the management team and the board of directors is 9.5 years and 12.3 years respectively.
Key information
Jeff Frelick
Chief executive officer
US$376.6k
Total compensation
| CEO salary percentage | 79.7% |
| CEO tenure | 4.9yrs |
| CEO ownership | 0.2% |
| Management average tenure | 9.5yrs |
| Board average tenure | 12.3yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$377k | US$300k | -US$9m |
| Sep 30 2023 | n/a | n/a | -US$7m |
| Jun 30 2023 | n/a | n/a | -US$6m |
| Mar 31 2023 | n/a | n/a | -US$5m |
| Dec 31 2022 | US$415k | US$300k | -US$1m |
| Sep 30 2022 | n/a | n/a | -US$3m |
| Jun 30 2022 | n/a | n/a | -US$2m |
| Mar 31 2022 | n/a | n/a | -US$2m |
| Dec 31 2021 | US$290k | US$245k | -US$2m |
| Sep 30 2021 | n/a | n/a | -US$2m |
| Jun 30 2021 | n/a | n/a | -US$2m |
| Mar 31 2021 | n/a | n/a | -US$2m |
| Dec 31 2020 | US$300k | US$240k | -US$2m |
| Sep 30 2020 | n/a | n/a | -US$2m |
| Jun 30 2020 | n/a | n/a | -US$2m |
| Mar 31 2020 | n/a | n/a | -US$3m |
| Dec 31 2019 | US$300k | US$240k | -US$3m |
| Sep 30 2019 | n/a | n/a | -US$4m |
| Jun 30 2019 | n/a | n/a | -US$4m |
| Mar 31 2019 | n/a | n/a | -US$4m |
| Dec 31 2018 | US$300k | US$240k | -US$4m |
| Sep 30 2018 | n/a | n/a | -US$6m |
| Jun 30 2018 | n/a | n/a | -US$8m |
| Mar 31 2018 | n/a | n/a | -US$6m |
| Dec 31 2017 | US$300k | US$240k | -US$7m |
Compensation vs Market: Jeff's total compensation ($USD376.60K) is below average for companies of similar size in the US market ($USD664.85K).
Compensation vs Earnings: Jeff's compensation has been consistent with company performance over the past year.
CEO
Jeff Frelick (57 yo)
4.9yrs
Tenure
US$376,600
Compensation
Mr. Jeffrey Frelick, also known as Jeff, has been the President and Chief Executive Officer at Bone Biologics Corporation since June 28, 2019. He served as Chief Operating Officer at Bone Biologics, Corp....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & President | 4.9yrs | US$376.60k | 0.24% $ 4.1k | |
| Chief Financial Officer | 9.5yrs | US$238.30k | 0.21% $ 3.6k | |
| Co-Founder & Member of Scientific Advisory Board | 20.3yrs | no data | no data |
9.5yrs
Average Tenure
Experienced Management: BBLG's management team is seasoned and experienced (9.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Member of Scientific Advisory Board | 19.3yrs | no data | no data | |
| Independent Director | 12.3yrs | US$76.88k | 0% $ 0 | |
| Member of Scientific Advisory Board | 19.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 19.3yrs | no data | no data | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Chairman of the Board | 9.8yrs | no data | 0.65% $ 10.8k | |
| Independent Director | 2.6yrs | US$76.88k | 0% $ 0 |
12.3yrs
Average Tenure
61yo
Average Age
Experienced Board: BBLG's board of directors are seasoned and experienced ( 12.3 years average tenure).